Covid19mathblog.com
Some more not so good stat on long covid – https://newatlas.com/health-wellbeing/long-covid-study-lancet-lasting-symptoms/
“A striking 76 percent of all patients reported at least one continuing symptom six months later. The most common lasting problem was fatigue or muscle weakness, reported by 63 percent of all patients. Around a quarter of the cohort also reported sleep difficulties and anxiety or depression.
A smaller subset of the cohort completed comprehensive pulmonary testing and more than half displayed persistent chest imaging abnormalities. The degree of ongoing lung damage six months later correlated with the severity of the disease during the patients’ acute phase of hospitalization.”
Another variant…. https://time.com/5928445/coronavirus-covid19-virus-variant/
“The Japanese Health Ministry has found a coronavirus variant in people arriving from Brazil that’s different from the ones in Britain and South Africa.
The variant was found in airport tests on a man in his 40s, a woman in her 30s and two teens, the ministry said Sunday. Japan was working with other nations, the WHO and other medical experts to analyze the new version of the virus, and it was still unclear whether available vaccines would work.
The man who tested positive had no symptoms upon arrival but was hospitalized after his breathing became difficult. The woman suffered head aches, one teen, a male, had a fever, while the other female teen had no symptoms, according to the ministry.”
Some good news….As noted many times I think a nasal spray is an obvious approach that should work given how the virus is getting into the system – https://www.jpost.com/health-science/nasal-spray-to-fight-covid-begins-clinical-trails-in-uk-654990
“The SaNOtize Nitric Oxide Nasal Spray (NONS), developed by a team of researchers in Vancouver, Canada, has proven to be 99.9% effective in killing the coronavirus in independent lab tests conducted at Utah State University’s Antiviral Research Institute.
Other studies have also shown a 95% reduction in COVID-19 infection based on rodent tests.
This unique treatment utilizes nitric oxide, which is produced in the human body, to directly combat the effects of SARS-CoV-2, the virus that causes COVID-19, and can be delivered via nasal spray, throat gargle or nasal lavage.”
One shot vaccine coming from J&J at the end of Jan – https://www.cnbc.com/2021/01/11/johnson-johnson-covid-vaccine-analysts-are-cautiously-optimistic.html
“J&J completed enrolment of its 45,000-participant phase three clinical trial for its single-dose vaccine candidate on December 17. Preliminary data from the trial is expected to be available by the end of the month.”
“With J&J’s technology, the vaccine is estimated to remain stable for at least three months at normal refrigerated temperatures so does not require new infrastructure to transport.”
“The company has committed to selling the vaccine on a not-for-profit basis for emergency pandemic use.
J&J entered into an agreement with the U.S. in August 2020 to deliver 100 million doses of the vaccine following approval or emergency use authorization by the FDA, and the option to purchase up to 200 million additional doses under a subsequent agreement.
The U.K. negotiated a deal in August to initially purchase 30 million doses of the J&J vaccine with an option to purchase up to 22 million additional doses. The EU signed a deal with J&J in October for the supply of up to 400 million doses.
J&J has also agreed to provide up to 500 million doses of its vaccine as part of an agreement in principle with The Vaccine Alliance (Gavi), which is responsible for equitable access to vaccines, including to lower-income countries via COVAX. These doses will be distributed through 2022 if the vaccine candidate is approved for use.”
Sunday reports are the best….US death under 2K – no other country above 1K
For the US it is still a CA story
More precisely it is a LA story
CA is very centralized whereas TX is dispersed
No peak being set for LA still…..